# Neuropeptides and Social Behavior

> **NCT01680718** · EARLY_PHASE1 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 160 (actual)

## Conditions studied

- Social Psychology

## Interventions

- **DRUG:** Intranasal oxytocin
- **DRUG:** Intranasal vasopressin
- **DRUG:** Intranasal placebo

## Key facts

- **NCT ID:** NCT01680718
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2015-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01680718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01680718, "Neuropeptides and Social Behavior". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01680718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*